Evidence map›Paper›PMID 32153233›Full record

Trial reportPediatric hematology and oncology2020

Sociodemographic and clinical characteristics associated with vitamin D status in newly diagnosed pediatric cancer patients.

Paula Aristizabal, Michael Sherer, Bianca P Perdomo, Esteban Castelao, Courtney D Thornburg, James Proudfoot, Elizabeth Jacobs, Ron S Newfield, Peter Zage, William Roberts and 1 more

Open access · greenAbstract readClinical TrialMulticenter StudyVideo-Audio Media
In one paragraph

Trial report in Pediatric hematology and oncology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 2 pooled it
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 2 syntheses or guidelines pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Bone Health Issues in the Pediatric Oncology Patient.Seminars in oncology nursing · 2022
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Paula AristizabalDepartment of Pediatrics, Division of Pediatric Hematology/Oncology University of California San Diego/Peckham Center for Cancer and Blood Disorders, Rady Children's Hospital San Diego, San Diego, CA, USA.ORCID http://orcid.org/0000-0003-0588-1532
Michael ShererSchool of Medicine, University of California San Diego, La Jolla, CA, USA.
Bianca P PerdomoDepartment of Pediatrics, Division of Pediatric Hematology/Oncology University of California San Diego/Peckham Center for Cancer and Blood Disorders, Rady Children's Hospital San Diego, San Diego, CA, USA.
Esteban CastelaoDepartment of Family Medicine and Public Health, University of California San Diego, La Jolla, CA, USA.
Courtney D ThornburgDepartment of Pediatrics, Division of Pediatric Hematology/Oncology University of California San Diego/Peckham Center for Cancer and Blood Disorders, Rady Children's Hospital San Diego, San Diego, CA, USA.
James ProudfootAltman Clinical and Translational Research Institute, University of California San Diego, La Jolla, CA, USA.
Elizabeth JacobsUniversity of Arizona Cancer Center and Mel and Enid Zuckerman College of Public Health, University of Arizona, Tucson, AZ, USA.
Ron S NewfieldDepartment of Pediatrics, Division of Pediatric Endocrinology, University of California San Diego, Rady Children's Hospital San Diego, San Diego, CA, USA.
Peter ZageDepartment of Pediatrics, Division of Pediatric Hematology/Oncology University of California San Diego/Peckham Center for Cancer and Blood Disorders, Rady Children's Hospital San Diego, San Diego, CA, USA.
William RobertsDepartment of Pediatrics, Division of Pediatric Hematology/Oncology University of California San Diego/Peckham Center for Cancer and Blood Disorders, Rady Children's Hospital San Diego, San Diego, CA, USA.
Maria Elena MartinezUniversity of California San Diego Moores Cancer Center, La Jolla, CA, USA.
University of California San Diego · USUniversity of Arizona · US

Funding

VIRAL MALIGNANCYP30CA023100 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jesse Nodora · 1985 to 2026
$124.9M
UC San Diego Clinical and Translational Research InstituteUL1TR001442 · NCATS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FIRESTEIN, GARY S, HOGARTH, MICHAEL · 2015 to 2024
$88.3M
Research Education CoreU54CA132384 · NCI · SAN DIEGO STATE UNIVERSITY · PI CRIPPS, RICHARD MATTHEW, CROWE, SHEILA E. · 2008 to 2022
$20.7M
Research Education CoreU54CA132379 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ARREDONDO, ELVA M, CROWE, SHEILA E. · 2008 to 2021
$16.1M
T35 Short Term Research Training GrantT35HL007491 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SAVOIA, MARIA CHRISTINA · 1985 to 2015
$2.8M
COMPRENDO: Adaptation and Implementation of a Peer-Navigation Intervention to Improve Research Literacy and Diversity in Pediatric Leukemia Clinical TrialsK08CA230306 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ARISTIZABAL, PAULA · 2018 to 2023
$1.4M
NCATS NIH HHS UL1 TR001442NCI NIH HHS K08 CA230306NCI NIH HHS P30 CA023100NCI NIH HHS U54 CA132379NCI NIH HHS U54 CA132384NHLBI NIH HHS T35 HL007491
6 · The paper itself

Abstract

Vitamin D deficiency and insufficiency are associated with serious sequelae in childhood cancer survivors. However, data on vitamin D deficiency in children with newly diagnosed cancer are scarce and the role of sociodemographic factors and vitamin D supplementation is largely unknown. We assessed vitamin D status and its socio-demographic and clinical correlates in 163 children with newly diagnosed cancer, using 25-hydroxy vitamin D (25(OH)D) concentrations and assessed longitudinal changes following vitamin D supplementation. Sixty-five percent of the patients with newly diagnosed cancer had low 25(OH)D concentrations. Fifty-two patients (32%) were vitamin D deficient (≤20 ng/mL 25(OH)D concentration), and 53(33%) were insufficient (21-29 ng/mL 25(OH)D concentration). Age over 10 (

Indexed as

Dietary SupplementsNeoplasmsVitamin D DeficiencyAdolescentChildCross-Sectional StudiesFemaleHumansMaleRetrospective StudiesVitamin D25-hydroxyvitamin DVitamin DCancer disparitiesnutritionpediatric cancersupplementationvitamin D

Identifiers

PMID32153233
PMCPMC7207243
OpenAlexW3011744513

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.